BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37172094)

  • 1. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma.
    Sun R; Han R; McCornack C; Khan S; Tabor GT; Chen Y; Hou J; Jiang H; Schoch KM; Mao DD; Cleary R; Yang A; Liu Q; Luo J; Petti A; Miller TM; Ulrich JD; Holtzman DM; Kim AH
    Sci Adv; 2023 May; 9(19):eade3559. PubMed ID: 37172094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of TREM2 in central nervous system cancers and peripheral cancers.
    Zhong J; Xing X; Gao Y; Pei L; Lu C; Sun H; Lai Y; Du K; Xiao F; Yang Y; Wang X; Shi Y; Bai F; Zhang N
    Cancer Cell; 2024 Jun; 42(6):968-984.e9. PubMed ID: 38788719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
    Peshoff MM; Gupta P; Oberai S; Trivedi R; Katayama H; Chakrapani P; Dang M; Migliozzi S; Gumin J; Kadri DB; Lin JK; Milam NK; Maynard ME; Vaillant BD; Parker-Kerrigan B; Lang FF; Huse JT; Iavarone A; Wang L; Clise-Dwyer K; Bhat KP
    Neuro Oncol; 2024 May; 26(5):826-839. PubMed ID: 38237157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.
    Sessa G; Podini P; Mariani M; Meroni A; Spreafico R; Sinigaglia F; Colonna M; Panina P; Meldolesi J
    Eur J Neurosci; 2004 Nov; 20(10):2617-28. PubMed ID: 15548205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
    Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
    Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice after systemic stimulation with Escherichia coli.
    Hoogland ICM; Yik J; Westhoff D; Engelen-Lee JY; Valls Seron M; Man WK; Houben-Weerts JHPM; Tanck MW; van Westerloo DJ; van der Poll T; van Gool WA; van de Beek D
    Neurosci Lett; 2022 Nov; 790():136894. PubMed ID: 36183964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
    Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
    J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
    Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
    J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2).
    Glebov K; Wunderlich P; Karaca I; Walter J
    J Neuroinflammation; 2016 Jan; 13():17. PubMed ID: 26792193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy.
    Molgora M; Esaulova E; Vermi W; Hou J; Chen Y; Luo J; Brioschi S; Bugatti M; Omodei AS; Ricci B; Fronick C; Panda SK; Takeuchi Y; Gubin MM; Faccio R; Cella M; Gilfillan S; Unanue ER; Artyomov MN; Schreiber RD; Colonna M
    Cell; 2020 Aug; 182(4):886-900.e17. PubMed ID: 32783918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas.
    Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Bosco DB; Huang T; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Qi F; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
    Neuro Oncol; 2024 May; 26(5):811-825. PubMed ID: 37941134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
    Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke.
    Hu M; Lin Y; Men X; Wang S; Sun X; Zhu Q; Lu D; Liu S; Zhang B; Cai W; Lu Z
    J Neuroinflammation; 2021 Apr; 18(1):90. PubMed ID: 33845849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
    Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
    J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages.
    Chen X; Zhao Y; Huang Y; Zhu K; Zeng F; Zhao J; Zhang H; Zhu X; Kettenmann H; Xiang X
    Glia; 2023 Nov; 71(11):2679-2695. PubMed ID: 37641212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.
    Li X; Montine KS; Keene CD; Montine TJ
    FASEB J; 2015 May; 29(5):1754-62. PubMed ID: 25593125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.
    Wang Q; Zheng K; Tan D; Liang G
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):140-146. PubMed ID: 36332476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
    Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
    Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iPSC-derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss.
    Penney J; Ralvenius WT; Loon A; Cerit O; Dileep V; Milo B; Pao PC; Woolf H; Tsai LH
    Glia; 2024 Feb; 72(2):452-469. PubMed ID: 37969043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.
    Wang Y; Cella M; Mallinson K; Ulrich JD; Young KL; Robinette ML; Gilfillan S; Krishnan GM; Sudhakar S; Zinselmeyer BH; Holtzman DM; Cirrito JR; Colonna M
    Cell; 2015 Mar; 160(6):1061-71. PubMed ID: 25728668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.